Treatment of SK28R melanoma cells with increasing doses of SRC inhibitors (Bos or Das) at different doses (10–500 nM) in combination with increasing doses of Vem significantly increased BRAFi sensitivity (Fig 5A). The gene discussed is SRC; the disease is melanoma.